SecBot SecBot

PRTA

PROTHENA CORP PUBLIC LTD CO
Nasdaq· Pharmaceutical Preparations· Inc. L2· CIK 0001559053 Biotech & Drug Discovery
$7.97 −0.19 (−2.33%)
Nov 16 4:00 PM ET · prev $8.16
Market cap
$422.6M
Small cap
Median target
$20.00
+151% · range $8.00–36.00
1 year
−22.2%
from $10.25 · Nov 17
30 days
−6.0%
from $8.48
52-week range
$7.89–11.51
−31% from high · low Nov 5
Avg volume 20D
449.3K
shares / day
Short interest
7.91M
≈15.4% of shares · −0.4%
Days to cover
15.7
at average volume
Insider net
+$13.1M
1 buyer · 2 sellers · since Apr 10
New fund stakes
0
Q3 2026 13F · 0 exits
Filing reports
20
analyzed by SecBot
SecBot read BULLISH 12 reports · 90 days
Balance 1 bearish · 7 bullish · 4 neutral oldest → newest, height = score
Avg score ·High conf. 8/12

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBULLISH

    1 insider bought $13.3M at an average $8.62. 2 insiders sold $136.0K. Price is 8% below their cost.

  • InstitutionsBULLISH

    Q3 2026: 17 added (0 new), 10 trimmed or exited.

  • EstimatesFALLING

    Current-quarter EPS estimate $0.740 → $0.525 over 90 days. 1 up, 0 down in 30 days.

  • Short sellersSTEADY

    Short interest −0.4% to 7.91M shares. 15.7 days to cover, ≈15.4% of shares.

  • TrendDOWNTREND

    6% below its 50-day average.

  • SocialQUIET

    No Reddit mentions this week. Last mention Nov 8.

Who's buying

13F· Q3 2026
0
new positions
0
exits
FundMoveSharesValue
MORGAN STANLEYTRIM617,311$5.2M
Qube Research & Technologies LtdTRIM462,862$3.9M
Quantinno Capital Management LPADD201,649$1.7M
BNP PARIBAS FINANCIAL MARKETSTRIM154,615$1.3M
Creative PlanningDOUBLED153,049$1.3M
Nuveen, LLCNEAR_EXIT103,492$867.3K
Invesco Ltd.ADD90,112$755.1K
BARCLAYS PLCADD63,989$536.2K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

Last action May 2026
12-month targets · 5 analysts

Price is below the lowest target. Median implies +151%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
May 8, 2026Citizens
MAINTAIN
MAINTAINMarket Outperform
Feb 20, 2026RBC Capital
MAINTAIN
MAINTAINSector Perform
Dec 1, 2025Citizens
MAINTAIN
MAINTAINMarket Outperform
Nov 7, 2025HC Wainwright & Co.
MAINTAIN
MAINTAINBuy
Nov 7, 2025RBC Capital
MAINTAIN
MAINTAINSector Perform
Oct 28, 2025Piper Sandler
MAINTAIN
MAINTAINOverweight

Insider ledger

Form 4
$13.3M
bought · 1 insider
$136.0K
sold · 2 insiders
−7.5%
vs their $8.62 cost
DateInsiderTypeValue
Nov 9, 2026
SCULLY WILLIAM P
10%+ Owner
Nov 9, 2026
BUY$1.2M
Nov 6, 2026
SCULLY WILLIAM P
10%+ Owner
Nov 6, 2026
GIFT916,444 sh
Oct 27, 2026
SCULLY WILLIAM P
10%+ Owner
Oct 27, 2026
GIFT566,444 sh
Oct 23, 2026
SCULLY WILLIAM P
10%+ Owner
Oct 23, 2026
BUY$403.5K
Oct 22, 2026
SCULLY WILLIAM P
10%+ Owner
Oct 22, 2026
BUY$818.5K
Oct 14, 2026
SCULLY WILLIAM P
10%+ Owner
Oct 14, 2026
BUY$84.6K
Oct 13, 2026
SCULLY WILLIAM P
10%+ Owner
Oct 13, 2026
BUY$835.5K
Oct 8, 2026
SCULLY WILLIAM P
10%+ Owner
Oct 8, 2026
BUY$770.9K

Earnings setup

Estimates
$0.53
EPS estimate, this quarter
−29%
estimate change, 90 days
1↑ 0↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q$0.53$0.30–$0.75-29.1%$19.9M
Next Q-$0.36-$0.36–-$0.36+12.2%$0.00
Current FY🔒 Fresh data, subscribers only
Next FY-$1.24-$1.37–-$1.11+18.4%$21.0M
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
5 drugs tracked · Drug pipeline →
Recent

Short side

FINRA· Oct 30, 2026
7,911,160
shares short
-0.4%
vs prior settlement
15.7
days to cover
≈15.4%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 13, 2026 SEC
Todd W. Fennell filed a Form 3 initial statement of beneficial ownership, indicating he has become a new insider…
3 · Impact 1/10
Nov 13, 2026 SEC
William P. Scully filed an amended Schedule 13G disclosing beneficial ownership of 6,404,846 ordinary shares of…
SC 13G/A · Impact 3/10
Nov 10, 2026 SEC
10% owner William Scully purchased $1.19M of PRTA stock in an open-market transaction, representing 0.29% of market…
INSIDER-BUY · Impact 5/10
Nov 9, 2026 Insider
SCULLY WILLIAM P bought 140,000 shares
10%+ Owner @ $8.53 ($1.2M)
Nov 6, 2026 Insider
SCULLY WILLIAM P gifted 916,444 shares
10%+ Owner
Nov 5, 2026 Earnings result
PRTA Q3 2026 Earnings: EPS $-0.32 (-48.4% vs est)
Oct 27, 2026 Insider
SCULLY WILLIAM P gifted 566,444 shares
10%+ Owner
Sep 30, 2026 Inst.
MORGAN STANLEY · TRIM
617,311 shares ($5.2M)
Reddit
Recent posts
All social signals and their track records

SecBot reports

20 filings · 11 bullish · 1 bearish · 8 neutral
All PRTA filing & press-release reports (20)